Evidence map›Paper›PMID 39497805›Full record

ArticleFrontiers in endocrinology2024

Pancreatic β-cells package double C2-like domain beta protein into extracellular vesicles via tandem C2 domains.

Diana Esparza, Carinna Lima, Sarah Abuelreich, Ima Ghaeli, Jinhee Hwang, Eunjin Oh, Ayelet Lenz, Angel Gu, Nan Jiang, Fouad Kandeel and 2 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Diana EsparzaDepartment of Molecular and Cellular Endocrinology, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute at City of Hope, Duarte, CA, United States.
Carinna LimaDepartment of Cancer Biology and Molecular Medicine, Beckman Research Institute at City of Hope, Duarte, CA, United States.
Sarah AbuelreichDepartment of Cancer Biology and Molecular Medicine, Beckman Research Institute at City of Hope, Duarte, CA, United States.
Ima GhaeliDepartment of Cancer Biology and Molecular Medicine, Beckman Research Institute at City of Hope, Duarte, CA, United States.
Jinhee HwangDepartment of Molecular and Cellular Endocrinology, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute at City of Hope, Duarte, CA, United States.
Eunjin OhDepartment of Molecular and Cellular Endocrinology, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute at City of Hope, Duarte, CA, United States.
Ayelet LenzDepartment of Molecular and Cellular Endocrinology, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute at City of Hope, Duarte, CA, United States.
Angel GuDepartment of Translational Research and Cellular Therapeutics, Beckman Research Institute at City of Hope, Duarte, CA, United States.
Nan JiangDepartment of Cancer Biology and Molecular Medicine, Beckman Research Institute at City of Hope, Duarte, CA, United States.
Fouad KandeelDepartment of Translational Research and Cellular Therapeutics, Beckman Research Institute at City of Hope, Duarte, CA, United States.
Debbie C ThurmondDepartment of Molecular and Cellular Endocrinology, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute at City of Hope, Duarte, CA, United States.
Tijana Jovanovic-TalismanDepartment of Cancer Biology and Molecular Medicine, Beckman Research Institute at City of Hope, Duarte, CA, United States.

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI John Charles Williams · 1985 to 2026
$86.3M
Regulation of Glucose Homeostasis by Munc18 ProteinsR01DK067912 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI THURMOND, DEBBIE C · 2004 to 2023
$6.5M
Targeting PAK1 to improve functional beta-cell mass and insulin sensitivityR01DK102233 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI THURMOND, DEBBIE C, VELUTHAKAL, RAJAKRISHNAN · 2014 to 2024
$3.3M
DOC2B-based therapeutics for prevention/remediation of type 2 diabetesR01DK112917 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI THURMOND, DEBBIE C · 2018 to 2021
$1.7M
DIABETES PREVENTION / RISK / OMICS / METABOLISM / THERAPY (PROMT) INTERDISCIPLINARY TRAININGT32DK131943 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI RAMA NATARAJAN, Debbie C Thurmond · 2023 to 2026
$478k
Regulating SNARE mechanisms to remediate glucose dyshomeostasisR56DK067912 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI FUEGER, PATRICK T., GARCIA-OCANA, ADOLFO · 2025 to 2025
$223k
NCI NIH HHS P30 CA033572NIDDK NIH HHS R01 DK067912NIDDK NIH HHS R01 DK102233NIDDK NIH HHS R01 DK112917NIDDK NIH HHS R56 DK067912NIDDK NIH HHS T32 DK131943
6 · The paper itself

Abstract

Introduction: Double C2-like domain beta (DOC2B) is a vesicle priming protein critical for glucose-stimulated insulin secretion in β-cells. Individuals with type 1 diabetes (T1D) have lower levels of DOC2B in their residual functional β-cell mass and platelets, a phenotype also observed in a mouse model of T1D. Thus, DOC2B levels could provide important information on β-cell dys(function). Objective: Our objective was to evaluate the DOC2B secretome of β-cells. In addition to soluble extracellular protein, we assessed DOC2B localized within membrane-delimited nanoparticles - extracellular vesicles (EVs). Moreover, in rat clonal β-cells, we probed domains required for DOC2B sorting into EVs. Method: Using Single Extracellular VEsicle Nanoscopy, we quantified EVs derived from clonal β-cells (human EndoC-βH1, rat INS-1 832/13, and mouse MIN6); two other cell types known to regulate glucose homeostasis and functionally utilize DOC2B (skeletal muscle rat myotube L6-GLUT4myc and human neuronal-like SH-SY5Y cells); and human islets sourced from individuals with no diabetes (ND). EVs derived from ND human plasma, ND human islets, and cell lines were isolated with either size exclusion chromatography or differential centrifugation. Isolated EVs were comprehensively characterized using dotblots, transmission electron microscopy, nanoparticle tracking analysis, and immunoblotting. Results: DOC2B was present within EVs derived from ND human plasma, ND human islets, and INS-1 832/13 β-cells. Compared to neuronal-like SH-SY5Y cells and L6-GLUT4myc myotubes, clonal β-cells (EndoC-βH1, INS-1 832/13, and MIN6) produced significantly more EVs. DOC2B levels in EVs (over whole cell lysates) were higher in INS-1 832/13 β-cells compared to L6-GLUT4myc myotubes; SH-SY5Y neuronal-like cells did not release appreciable DOC2B. Mechanistically, we show that DOC2B was localized to the EV lumen; the tandem C2 domains were sufficient to confer sorting to INS-1 832/13 β-cell EVs. Discussion: Clonal β-cells and ND human islets produce abundant EVs. In cell culture, appreciable DOC2B can be packaged into EVs, and a small fraction is excreted as a soluble protein. While DOC2B-laden EVs and soluble protein are present in ND plasma, further studies will be necessary to determine if DOC2B originating from β-cells significantly contributes to the plasma secretome.

Indexed as

Calcium-Binding ProteinsExtracellular VesiclesInsulin-Secreting CellsNerve Tissue ProteinsAnimalsHumansInsulin SecretionMiceProtein DomainsRatsCalcium-Binding ProteinsDoc2b protein, mouseNerve Tissue ProteinsDouble C2-like domain beta protein (DOC2B)extracellular vesicles (EVs)pancreatic islets β-cellssingle EV analysisSingle Extracellular VEsicle Nanoscopy (SEVEN)

Identifiers

PMID39497805
PMCPMC11532064

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.